全文获取类型
收费全文 | 3781篇 |
免费 | 323篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 314篇 |
妇产科学 | 45篇 |
基础医学 | 148篇 |
口腔科学 | 203篇 |
临床医学 | 597篇 |
内科学 | 928篇 |
皮肤病学 | 91篇 |
神经病学 | 155篇 |
特种医学 | 118篇 |
外科学 | 494篇 |
综合类 | 170篇 |
一般理论 | 4篇 |
预防医学 | 486篇 |
眼科学 | 38篇 |
药学 | 102篇 |
2篇 | |
中国医学 | 75篇 |
肿瘤学 | 140篇 |
出版年
2024年 | 8篇 |
2023年 | 57篇 |
2022年 | 132篇 |
2021年 | 159篇 |
2020年 | 169篇 |
2019年 | 97篇 |
2018年 | 73篇 |
2017年 | 40篇 |
2016年 | 50篇 |
2015年 | 44篇 |
2014年 | 36篇 |
2013年 | 51篇 |
2012年 | 222篇 |
2011年 | 306篇 |
2010年 | 140篇 |
2009年 | 77篇 |
2008年 | 245篇 |
2007年 | 303篇 |
2006年 | 296篇 |
2005年 | 282篇 |
2004年 | 291篇 |
2003年 | 324篇 |
2002年 | 203篇 |
2001年 | 204篇 |
2000年 | 83篇 |
1999年 | 28篇 |
1998年 | 22篇 |
1997年 | 14篇 |
1996年 | 8篇 |
1995年 | 5篇 |
1993年 | 3篇 |
1991年 | 18篇 |
1990年 | 13篇 |
1989年 | 12篇 |
1988年 | 9篇 |
1987年 | 8篇 |
1986年 | 7篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 13篇 |
1980年 | 4篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 5篇 |
1975年 | 10篇 |
1974年 | 5篇 |
1973年 | 4篇 |
1965年 | 2篇 |
1958年 | 2篇 |
排序方式: 共有4126条查询结果,搜索用时 640 毫秒
111.
112.
113.
114.
115.
Slade M Taber D Clarke MM Johnson C Kapoor D Leikin JB Naylor M Neal DA Novak J Steiner D Temkin T Teodo P Tippy A Tronc V Yohanna D Zehr E Zun L;Illinois Hospital Association Behavioral Health Constituency Section Steering Committee its Best Practices Task Force 《Disease-a-month : DM》2007,53(11-12):536-580
116.
117.
118.
为了规范我国儿童康复相关发育性疾病的诊断和命名,保证临床专业人员能够早期、精准的诊断和治疗这类疾病,中华医学会儿科学分会康复学组组织相关专家多次讨论,并结合我国目前实际情况制定了本建议。本建议的主要内容包括高危儿、发育迟缓、全面性发育迟缓、语言障碍、智力障碍、孤独症谱系障碍及发育性协调障碍的诊断与命名现状、评估及专家建议,为临床专业人员在儿童发育性疾病的诊断、评估及治疗方面提供一定参考与指导。
该文的微信推文请扫描下方二维码查看! 相似文献
119.
Economic costs of diabetes in the US in 2002 总被引:40,自引:0,他引:40
OBJECTIVE: Diabetes is the fifth leading cause of death by disease in the U.S. Diabetes also contributes to higher rates of morbidity-people with diabetes are at higher risk for heart disease, blindness, kidney failure, extremity amputations, and other chronic conditions. The objectives of this study were 1). to estimate the direct medical and indirect productivity-related costs attributable to diabetes and 2). to calculate and compare the total and per capita medical expenditures for people with and without diabetes. RESEARCH DESIGN AND METHODS: Medical expenditures were estimated for the U.S. population with and without diabetes in 2002 by sex, age, race/ethnicity, type of medical condition, and health care setting. Health care use and total health care expenditures attributable to diabetes were estimated using etiological fractions, calculated based on national health care survey data. The value of lost productivity attributable to diabetes was also estimated based on estimates of lost workdays, restricted activity days, prevalence of permanent disability, and mortality attributable to diabetes. RESULTS-Direct medical and indirect expenditures attributable to diabetes in 2002 were estimated at 132 billion US dollars. Direct medical expenditures alone totaled 91.8 billion US dollars and comprised 23.2 billion US dollars for diabetes care, 24.6 billion US dollars for chronic complications attributable to diabetes, and 44.1 billion US dollars for excess prevalence of general medical conditions. Inpatient days (43.9%), nursing home care (15.1%), and office visits (10.9%) constituted the major expenditure groups by service settings. In addition, 51.8% of direct medical expenditures were incurred by people >65 years old. Attributable indirect expenditures resulting from lost workdays, restricted activity days, mortality, and permanent disability due to diabetes totaled 39.8 billion US dollars. U.S. health expenditures for the health care components included in the study totaled 865 billion US dollars, of which 160 billion US dollars was incurred by people with diabetes. Per capita medical expenditures totaled 13243 US dollars for people with diabetes and 2560 US dollars for people without diabetes. When adjusting for differences in age, sex, and race/ethnicity between the population with and without diabetes, people with diabetes had medical expenditures that were approximately 2.4 times higher than expenditures that would be incurred by the same group in the absence of diabetes. CONCLUSIONS: The estimated 132 billion US dollars cost likely underestimates the true burden of diabetes because it omits intangibles, such as pain and suffering, care provided by nonpaid caregivers, and several areas of health care spending where people with diabetes probably use services at higher rates than people without diabetes (e.g., dental care, optometry care, and the use of licensed dietitians). In addition, the cost estimate excludes undiagnosed cases of diabetes. Health care spending in 2002 for people with diabetes is more than double what spending would be without diabetes. Diabetes imposes a substantial cost burden to society and, in particular, to those individuals with diabetes and their families. Eliminating or reducing the health problems caused by diabetes through factors such as better access to preventive care, more widespread diagnosis, more intensive disease management, and the advent of new medical technologies could significantly improve the quality of life for people with diabetes and their families while at the same time potentially reducing national expenditures for health care services and increasing productivity in the U.S. economy. 相似文献
120.
中华医学会器官移植学分会 《中华移植杂志(电子版)》2020,14(3):129-135
目前,心肺联合移植已成为公认治疗终末期心肺疾病的有效方法。中华医学会器官移植学分会组织心脏和肺移植专家,结合当前国内外心肺联合移植形势,总结国际指南和相关研究最新进展,并结合国内临床实践经验,从心肺联合移植的适应证和禁忌证、手术时机选择、供者选择、供器官获取和保护以及手术要点和术后管理等方面制订《中国心肺联合移植操作规范(2019版)》。 相似文献